Dosimetric Impact of Titanium Alloy Implant in Spinal IMRT Plan / 中国医疗器械杂志

The purpose of this study is to establish and apply a correction method for titanium alloy implant in spinal IMRT plan, a corrected CT-density table was revised from normal CT-density table to include the density of titanium alloy implant. Dose distribution after and before correction were calculated and compared to evaluate the dose deviation. Plans were also copied to a spinal cancer simulation phantom. A titanium alloy fixation system for spine was implanted in this phantom. Plans were recalculated and compared with the measurement result. The result of this study shows that the max dose of spinal cord showed significant difference after correction, and the deviation between calculation results and measurement results was reduced after correction. The method for expanding the range CT-density table, which means that the density of titanium alloy was included, can reduce the error in calculation.

Analysis of Imaging Performance Standards of CBCT X-IGRT System Used in Radiotherapy / 中国医疗器械杂志

This article briefly describes the imaging performance standards of the kilovolt X-ray image guidance system used in radiotherapy, analyzes the main aspects that should be considered in the image quality of X-IGRT system, and focuses on parameters that should be considered in the imaging performance evaluation criteria of the CBCT X-IGRT. The purpose is to sort out the imaging performance evaluation standards of kilovolt X-IGRT system, clarify the image quality requirements of X-IGRT equipment, and reach a consensus when evaluating the imaging performance of X-IGRT system.

Structural Design and Penumbra Analysis of Dynamic Multi-leaf Collimator Leaf End / 中国医疗器械杂志

Dynamic multi-leaf collimator, which has the function of radiation beam shaping, is a key executive component of tumor precise radiotherapy, and plays a core role in improving the accuracy, efficiency and quality of radiotherapy. A new type of collimator leaf end structure with circular arc and plane combination was studied, and collimator penumbra performance analysis model combining analytical expression and graphic analysis was developed. The influence of leaf end structure on penumbra was analyzed quantitatively, and a set of three-dimensional structure design of dynamic multi-leaf collimator was completed. The feasibility of the structural design and analysis model was verified through experimental measurements.

Feasibility Study of Beam Angle Optimization Based on Scripts in Automated-planning for Liver Cancer / 中国医疗器械杂志

OBJECTIVE@#To study the feasibility and potential benefits of beam angle optimization (BAO) to automated planning in liver cancer.@*METHODS@#An approach of beam angle sampling is proposed to implement BAO along with the module Auto-planning in treatment planning system (TPS) Pinnacle. An in-house developed plan quality metric (PQM) is taken as the preferred evaluating method during the sampling. The process is driven automatically by in-house made Pinnacle scripts both in sampling and scoring. In addition, dosimetry analysis and physician's opinion are also performed as the supplementary and compared with the result of PQM.@*RESULTS@#It is revealed by the numerical analysis of PQM scores that only 15% patients whose superior trials evaluated by PQM are also the initial trials. Gantry optimization can bring benefit to plan quality along with auto-planning in liver cancer. Similar results are provided by both dose comparison and physician's opinion.@*CONCLUSIONS@#It is possible to introduce a full automated approach of beam angle optimization to automated planning process. The advantages of this procedure can be observed both in numerical analysis and physician's opinion.

Progress in Development of Dose Verification System Software KylinRay-Dose4D / 中国医疗器械杂志

Advanced radiotherapy technology enables the dose to more accurately conform to the tumor target area of the patient, providing accurate treatment for the patient, but the gradient of the patient's radiation dose at the tumor edge is getting larger, which putting forward higher requirements for radiotherapy dose verification. The dose verification system software KylinRay-Dose4D can verify the patient's pre-treatment plan and the in vivo/on-line dose during the patient's treatment, providing important reference for the physicist to modify the radiotherapy plan and ensuring that the patient receives accurate treatment. This study introduces the overall design and key technologies of KylinRay-Dose4D, and tests the pre-treatment plan dose checking calculation and 2D/3D dose verification through clinical cases. The test results showed that the 2D/3D gamma pass rate (3 mm/3%) of KylinRay-Dose4D reconstructed dose compared with TPS plan dose and measured dose is larger than 95%, which indicating that the reconstructed dose of KylinRay-Dose4D meets the requirement of clinical application.

Application of PET-LINAC in Biology-guided Radiotherapy / 中国医疗器械杂志

Biology-guided radiotherapy (BgRT) is a novel technique of external beam radiotherapy, combining positron emission tomography-computed tomography (PET-CT) with a linear accelerator (LINAC). The key innovation is to utilize PET signals from tracers in tumor tissues for real-time tracking and guiding beamlets. Compared with a traditional LINAC system, a BgRT system is more complex in hardware design, software algorithm, system integration and clinical workflow. RefleXion Medical has developed the world's first BgRT system. Nevertheless, its actively advertised function, PET-guided radiotherapy, is still in the research and development phase. In this review study, we presented a number of issues related to BgRT, including its technical advantages and potential challenges.

Leak and Scattering Assessment by Optically Stimulated Luminescence Dosimetry in a Helical Linear Accelerator / Valoración de Fuga y Dispersión por medio de Dosimetría de Luminiscencia Estimulada Ópticamente (OSL) en un Acelerador Lineal Helicoidal

Radiation absorbed doses to organs outside the radiation therapy treatment beam can be significant and therefore of clinical interest. Two sets of out-of-beam measurements were performed measuring the leak dose and the scattered dose, at 5 points within the accelerator components (accelerator tube and collimator) and at 21 points on the equipment and surroundings based on a positioning scheme. For this purpose, 52 Optically Stimulated Luminescence (OSL) dosimeters were used in a latest generation helical linear accelerator. Of the 200 cGy fired at a cheese-like phantom, 0.332% of the out-of-beam dose contribution was found to come from the leak and 0.784% was transformed into scattering. For these dose values, estimates of the risk of second tumors in long-term survivors indicate a reduced probability of acquiring a second secondary radiation malignancy, based on information from the 1990 BEIR Committee report.

La dosis absorbida de radiación a órganos fuera del haz de tratamiento de radioterapia puede ser significativa y, por lo tanto, de interés clínico. Se realizaron dos sets de mediciones fuera del haz para determinar la dosis de fuga y la dosis dispersa, en 5 puntos dentro de los componentes del acelerador (tubo de aceleración y colimador) y 21 puntos en el equipo y alrededores basado en un esquema de posicionamiento. Para este fin se utilizaron 52 dosímetros de luminiscencia estimulada ópticamente (OSL, Optically Stimulated Luminescence), en un acelerador lineal helicoidal de última generación. De los 200 cGy disparados a un maniquí tipo queso, se encontró que el 0.332% de la contribución de dosis fuera del haz provenía de la fuga y 0.784% se transforma en dispersión. Para estos valores de dosis, las estimaciones del riesgo de segundos tumores en los supervivientes a largo plazo indican una reducida probabilidad de contraer una segunda malignidad por radiación secundaria, según la información del informe del Comité BEIR de 1990.

Impact of multi-leaf collimator positioning accuracy on quality control of volumetric modulation arc therapy plan for cervical cancer treated with Elekta linear accelerator / 南方医科大学学报

OBJECTIVE@#To investigate the influence of positioning accuracy of the multi-leaf collimators (MLC) on the passing rate of the plan dose verification for volumetric modulation arc therapy (VMAT) of cervical cancer using an Elekta linear accelerator.@*METHODS@#The dose distributions were measured using Sun Nuclear's Mapcheck and Arccheck semiconductors matrix before and after MLC calibration in30 cervical cancer patients undergoing VMAT. Dosimetric comparisons were performed with 2D and 3D gamma passing rates of 3%, 3 mm and 2%, and 2 mm. The 3D gamma distribution was reconstructed with respect to the patient's anatomy using 3DVH software to evaluate the possible influence of MLC positioning accuracy.@*RESULTS@#Before and after MLC calibration, the gamma passing rates of Mapcheck were (88.80±1.81)% and (99.25 ± 0.53)% under 3% and 3 mm standard, respectively, with an average increase of 10.45%. The corresponding gamma passing rates of Arccheck were (87.61±1.98)% and (98.13±0.99)%, respectively, with an average increase of 10.52%. The gamma passing rates of 3DVH were (89.87±2.28)% and (98.3±1.15)%, respectively, with an average increase of 8.43%.@*CONCLUSION@#The MLC positioning accuracy is one of the main factors influencing dosimetric accuracy of VMAT for cervical cancer. The application of Autocal software facilitates MLC calibration and improves the accuracy and safety of VMAT delivery for cervical cancer.

Comportamiento dosimétrico de un sistema de planificación mediante curvas de calibración de densidades electrónicas relativas / Dosimetric behaviour of a planning system through calibration curves of relative electron density

En esta investigación se planteó como objetivo la verificación del comportamiento dosimétrico del Sistema de Planificación de Tratamiento (TPS) de Radioterapia mediante las curvas de calibración de Densidades Electrónicas Relativas (DER). Este estudio se realizó en el Hospital de la Sociedad de Lucha Contra el Cáncer (SOLCA) Núcleo Loja, usando un fantoma antropomorfo CIRS 062M y un tomógrafo Toshiba Activion 16. Para determinar la nueva curva de calibración DER se tomaron los valores de densidades electrónicas especificadas en el manual del fantoma y las Unidades Hounsfield de la imagen tomográfica. Se realizó controles de calidad dosimétricos y verificación dosimétrica en tres casos clínicos: tórax, pelvis y cráneo; para realizar las pruebas dosimétricas se utilizó un acelerador CLINAC CX, cámara de ionización PTW tipo Farmer con volumen sensible de 0,6 cm3 y un electrómetro PTW UNIDOS E. Los resultados mostraron que las medidas para cada inserto del fantoma en ningún caso excedieron los límites establecidos de ± 20 UH, para el tomógrafo y el TPS; las pruebas de control de calidad no superaron el límite máximo de desviaciones en el cálculo de dosis absorbida por el TPS y la obtenida por medición de ± 4 % establecida por la IAEA y las verificaciones dosimétricas en tórax, pelvis y cráneo, determinaron que las desviaciones en el cálculo de la dosis absorbida por el TPS y la obtenida por medición no superaban la tolerancia del ± 5 % establecida por la ICRU.

In this research, the aim was to verify the dosimetric behavior of the Radiotherapy Treatment Planning System (TPS) using the Relative Electron Density (DER) calibration curves. This study was carried out at the SOLCA (Society of Fight Against Cancer) hospital in Loja, using an CIRS model 062M anthropomorphic phantom and a Toshiba Activion 16 tomograph. To determine the new DER calibration curve, the values of the electron densities specified in the manual of the phantom and the Hounsfield Units of the tomographic image were taken. Dosimetric quality controls were made in the location of three clinical cases: thorax pelvis and skull; used a CLINAC CX accelerator was used to perform the dosimetric tests, PTW ionization chamber type Farmer with sensitive volume of 0.6 cm3 and a PTW UNIDOS E electrometer. The results showed that the measurements for each insert of the phantom in no case exceeded the established limits of ± 20 UH, for the tomograph and the TPS; the quality control tests did not exceed the maximum limit of deviations in the calculation of dose absorbed by the TPS and the one obtained by measurement of ± 4% established by the IAEA and the clinical planning in the thorax, pelvis and skull, determine that the deviations in the calculation of the dose absorbed by the TPS and that obtained by measurement, they do not exceed the tolerance of ± 5% established by the ICR.

Accuracy of the dose delivery in prostate cancer patients-using an electronic portal imaging device [EPID]

Background: To correct patient positioning errors [setup errors] during prostate cancer treatment using EPID and fiducial gold markers, to improve the accuracy of the dose delivery in these patients

Materials and Methods: Fifteen patients with localized prostate carcinoma after implantation of fiducial gold markers in their prostate gland underwent the five-field IMRT planning technique. The plan was prepared in accordance with ICRU 50 guidance [PTV to receive 95-107% dose]. The software program reconstructed the three-dimensional position of the markers from the different Beams Eye Views [BEV]. The discrepancies of the seeds' positions [prostate surrogate] between plan and daily images were calculated three dimensionally. Then, necessary corrections were applied to match the prostate fiducial markers in the portal image with the BEV image in the planned one by moving the couch in the X, Y and Z directions

Results: Data from 15 patients and 469 fractions of radiotherapy were analyzed in this study. Two sets of data were available from EPID software before and after 3D set-up corrections. The mean of the population displacement in Left /Right [L/R], Anterior/Posterior [A/P] and Crania/Caudal [C/C] directions were 0.5, -1.0 and 2.4mm before, and -0.1, -0.5 and 0.9mm after corrections, respectively. The systematic and random errors for the measured populations in the three mentioned directions were 2.4, 2.7 and 2mm and 6.4, 5.9 and 6.1mm before corrections, and 1.1, 2.4 and 1.4mm and 3.8, 3.9 and 3.6mm after corrections, correspondingly

Conclusion: This study provides further evidence that using gold markers in the prostate improves dose delivery to the prostate. Also, it has been demonstrated that the EPID can be a powerful tool in the reduction of treatment setup errors and the quality assurance and verification of complex treatments

Dosimetric Effects of Magnetic Resonance Imaging-assisted Radiotherapy Planning: Dose Optimization for Target Volumes at High Risk and Analytic Radiobiological Dose Evaluation

Based on the assumption that apparent diffusion coefficients (ADCs) define high-risk clinical target volume (aCTVHR) in high-grade glioma in a cellularity-dependent manner, the dosimetric effects of aCTVHR-targeted dose optimization were evaluated in two intensity-modulated radiation therapy (IMRT) plans. Diffusion-weighted magnetic resonance (MR) images and ADC maps were analyzed qualitatively and quantitatively to determine aCTVHR in a high-grade glioma with high cellularity. After confirming tumor malignancy using the average and minimum ADCs and ADC ratios, the aCTVHR with double- or triple-restricted water diffusion was defined on computed tomography images through image registration. Doses to the aCTVHR and CTV defined on T1-weighted MR images were optimized using a simultaneous integrated boost technique. The dosimetric benefits for CTVs and organs at risk (OARs) were compared using dose volume histograms and various biophysical indices in an ADC map-based IMRT (IMRTADC) plan and a conventional IMRT (IMRTconv) plan. The IMRTADC plan improved dose conformity up to 15 times, compared to the IMRTconv plan. It reduced the equivalent uniform doses in the visual system and brain stem by more than 10% and 16%, respectively. The ADC-based target differentiation and dose optimization may facilitate conformal dose distribution to the aCTVHR and OAR sparing in an IMRT plan.

Computational study on the geometry optimization and excited - state properties of riboflavin by arguslab 4.0.1

Riboflavin [vitamin B[2]] belongs to a group of respiratory enzymes that occur widely in animals and plants participating in vital oxidation- reduction processes in the body. A computational study was conducted on riboflavin by ArgusLab 4.0.1 to obtain the most active conformation of riboflavin and to analyze its excited-state properties. The best conformation of riboflavin was found to be -199.2173 kcal/mol which is the minimum potential energy calculated by geometry convergence function by ArgusLab software; performed according to Hartree-Fock calculation method. Electronic transition states [ground and excited], were also calculated and visualized by semi-empirical ZINDO method by ArgusLab from which molecular properties such as energies, wave function and dipole moments were established. All the results obtained from geometry optimization and excited-state properties lead us to delineate the active sites with charged groups of riboflavin to interact with the receptors. Such types of investigations are significant for drug -receptor interactions

Radioterapia conformada en pacientes con cáncer de próstata. Experiencia de tres años en el Instituto Nacional de Cancerología de Colombia / Conformal Radiotherapy in Patients with Prostate Cancer A Three-Year Study at the National Cancer Institute of Colombia

Objetivo: Describir las características clínicas y demográficas y la supervivencia libre de cualquier evento y toxicidad en pacientes con cáncer localizado de próstata, tratados con radioterapia conformada en el Instituto Nacional de Cancerología. Métodos: Se revisaron los registros de pacientes tratados con radioterapia conformada entre enero del 2003 y diciembre del 2006. Se realizaron análisis descriptivos y se analizó la supervivencia mediante el método de Kaplan-Meier. Resultados: Se trataron 196 pacientes y se incluyeron 114 en el análisis. La mediana de seguimiento fue de 14,4 meses. La supervivencia libre de enfermedad, a 30 meses, fue de 74%. Se presentaron seis eventos en el grupo de alto riesgo y tres en el de riesgo intermedio; no se presentaron eventos en el de bajo riesgo. La supervivencia libre de recaída fue de 100%, 73% y 63% para los riesgos bajo, intermedio y alto, respectivamente. La toxicidad crónica urinaria no preexistente de cualquier grado fue de 12,8%; la rectal, de 10,8%, y la sexual, de 18,3%. Conclusiones: El seguimiento fue corto y limita la posibilidad de hacer comparaciones con series internacionales. No se demostraron diferencias estadísticamente significativas en la supervivencia libre de recaída, según grupos de riesgo; sin embargo, los eventos se presentaron acordes con el riesgo. Un tamaño de muestra superior podría haber incrementado la potencia del estudio para detectar estas diferencias. La toxicidad rectal, sexual y urinaria no se midió de manera sistemática, por lo cual los resultados no son concluyentes. Se deben implementar guías para definir el manejo con hormonoterapia.

Objective: To describe clinical and demographic characteristics, event free survival, and the toxicity in prostate cancer patients treated with conformal radiotherapy at the National Cancer Institute of Colombia. Methods: Case histories of patients treated with conformal radiotherapy between January, 2003 and December, 2006 were reviewed. Descriptive analyses were carried out and a survival analysis was performed with the Kaplan-Meier method. Results: One hundred and ninety-six patients were treated, 114 of whom were included in the analyses. Median follow-up was 14.4 months. Disease free survival at month 30 was 74%. Six events occurred in the high risk group, three in the intermediate risk group, and none in the low risk group. Relapse free survival was 100%, 73% and 67% for the low, intermediate, and high risk groups, respectively. Non pre-existent chronic toxicity of any degree was: 12.8%, urinary; 10.8%, rectal; and 18.3%, sexual. Conclusions: Follow-up was short and the possiblity of making comparisons with international series was limited. According to risk group, no statistically significant differences were shown for relapse free survival; however, events occurred in accordance with level of risk. A larger sample group could have enhanced the study´s potential to detect these differences. Rectal, sexual and urinary toxicities were not measured systematically, hence the results are not conclusive. Guidelines should be adopted for the application of hormonotherapy.

Field-in-field technique for upper abdominal malignancies in clinical radiotherapy.

BACKGROUND: In upper abdominal malignancies (UAM), due to the presence of multiple inhomogeneous tissues, a wedge-based conformal treatment planning results in high-dose regions inside the target volume. AIM: This study was designed to explore the feasibility of using a field-in-field (FIF) technique in different UAM and its efficacy in reducing the high-dose regions. MATERIALS AND METHODS: Twelve patients of UAM (which included malignancies of the gastroesophageal junction, stomach, gall bladder, and pancreas) were selected for this study. Computed tomography (CT) scans were performed and three-dimensional conformal wedge plans were generated for all the cases. The same plan was copied with the wedges removed and a FIF plan was generated. The two plans were compared for mean, maximum, and median doses; dose received by 2% (D2) and 98% (D98) of the target volume; volume receiving> 107% (V > 107%) and < 95% (V Statistical Analysis: Statistical analysis was performed with SPSS, version 10.0. RESULTS: For all the cases, the FIF technique was better than wedge-based planning in terms of maximum dose, D2, V > 107%, and CI; there was a statistically significant reduction in monitor units. With regard to doses to critical structures, there was marginal dose reduction for the kidneys and spinal cord with FIF as compared to wedge-based planning. CONCLUSION: The FIF technique can be employed for UAM in place of wedge-based conformal treatment plans.

Multi-institutional Comparison of Intensity Modulated Radiation Therapy (IMRT) Planning Strategies and Planning Results for Nasopharyngeal Cancer

The intensity-modulated radiation therapy (IMRT) planning strategies for nasopharyngeal cancer among Korean radiation oncology facilities were investigated. Five institutions with IMRT planning capacity using the same planning system were invited to participate in this study. The institutions were requested to produce the best plan possible for 2 cases that would deliver 70 Gy to the planning target volume of gross tumor (PTV1), 59.4 Gy to the PTV2, and 51.5 Gy to the PTV3 in which elective irradiation was required. The advised fractionation number was 33. The planning parameters, resultant dose distributions, and biological indices were compared. We found 2-3-fold variations in the volume of treatment targets. Similar degree of variation was found in the delineation of normal tissue. The physician-related factors in IMRT planning had more influence on the plan quality. The inhomogeneity index of PTV dose ranged from 4 to 49% in Case 1, and from 5 to 46% in Case 2. Variation in tumor control probabilities for the primary lesion and involved LNs was less marked. Normal tissue complication probabilities for parotid glands and skin showed marked variation. Results from this study suggest that greater efforts in providing training and continuing education in terms of IMRT planning parameters usually set by physician are necessary for the successful implementation of IMRT.

A dose verification method for high-dose-rate brachytherapy treatment plans.

AIM: To evolve a fast dose verification method for high-dose-rate (HDR) brachytherapy treatment plans and to demonstrate its applicability in different clinical cases. MATERIALS AND METHODS: We developed a software tool in VC++ for the Varisource HDR unit for HDR dosimetry plan verification using TG-43 parameters. HDR treatment dosimetry of a number clinical cases using Varisource was verified by comparison with the treatment planning system (TPS). RESULTS: A number of different types of clinical cases treated by Varisource were evaluated. TPS calculated dose values and verification code calculated dose values were found to agree to within 3% for most of the dose calculation points. CONCLUSIONS: We have validated with clinical cases a fast and independent dose verification method of the dosimetry at selected points for HDR brachytherapy treatments plan using TG-43 parameters. This can be used for the verification of the TPS calculated dose at various points. The code is written to work with Varisource, but it can conceivably be modified for other sources also by using the fitted constant of the respective source.

Does the fluence map editing in electronic tissue compensator improve dose homogeneity in bilateral field plan of head and neck patients?

The purpose of this study was to evaluate the effect of fluence map editing in electronic tissue compensator (ETC) on the dose homogeneity for head and neck cancer patients. Treatment planning using 6-MV X-rays and bilateral field arrangement employing ETC was carried out on the computed tomography (CT) datasets of 20 patients with head and neck cancer. All the patients were planned in Varian Eclipse three-dimensional treatment planning system (3DTPS) with dynamic multileaf collimator (DMLC). The treatment plans, with and without fluence editing, was compared and the effect of pre-editing and post-editing the fluence maps in the treatment field was evaluated. The skin dose was measured with thermoluminescent dosimeters (TLDs) and was compared with the skin dose estimated by TPS. The mean percentage volume of the tissue receiving at least 107% of the prescription dose was 5.4 (range 1.5-10; SD 2.4). Post-editing fluence map showed that the mean percentage volume of the tissue receiving at least 107% of the prescription dose was 0.47 (range 0.1-0.9; SD 0.3). The mean skin dose measured with TLD was found to be 74% (range 71-80%) of the prescribed dose while the TPS showed the mean skin dose as 85% (range 80-90%). The TPS overestimated the skin dose by 11%. Fluence map editing thus proved to be a potential tool for improving dose homogeneity in head and neck cancer patients planned with ETC, thus reducing the hot spots in the treatment region as well. The treatment with ETC is feasible with DMLC and does not take any additional time for setup or delivery. The method used to edit the fluence maps is simple and time efficient. Manual control over a plan is essential to create the best treatment plan possible.

Multileaf collimator transmission from the first Hi-Art II helical tomotherapy machine in India.

The purpose of this study was to measure the multileaf collimator (MLC) transmission from the first Hi-Art II tomotherapy machine installed at the Advanced Center for Treatment, Research, and Education in Cancer (ACTREC). The MLC transmission was measured with an A1SL ion chamber and the radiographic extended dose range (EDR2) film in virtual water slabs at 1.5-cm depth with a source-to-surface distance of 85 cm. The MLC transmission was measured for 30 s with all leaves open and for 360 s with all leaves closed. The movable jaws were set to the calibration field size of 5 x 40 cm at isocenter. The MLC transmission was found to be 0.3% with the ion chamber and 0.32% with the film. Thus, the MLC transmission value was found well within the manufacturer tolerance of 0.5%. MLC can safely be used for the beam modulation during intensity-modulated radiotherapy (IMRT) to deliver accurate doses to the patients.